Close
Loading...
CONTACT US
:
:
:
Call us at:
:
:
:
Fax:
Email:

ETFDH

Products

Loading...

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Background

Electron transfer flavoprotein dehydrogenase (ETFDH), also known as electron-transferring-flavoprotein dehydrogenase or ETF-ubiquinone oxidoreductase (ETF-QO), is encoded by the ETFDH gene on chromosome 4q32.1. The gene produces a 617-amino-acid precursor protein of approximately 67 kDa that is targeted to mitochondria and processed to a mature 64-kDa protein. ETFDH is a monomeric flavoprotein integrated into the inner mitochondrial membrane, containing one molecule of FAD and a 4Fe-4S cluster. The three-dimensional structure obtained by X-ray crystallography reveals a monomeric protein with three functional domains packed in close proximity: an FAD-binding domain, a 4Fe-4S cluster domain, and a ubiquinone (UQ)-binding domain, with the FAD in an extended conformation buried deeply within its functional domain. Two amino acids within the UQ-binding domain are highly conserved and are required for the interaction between ETFDH and coenzyme Q.

ETFDH functions as ETF:ubiquinone oxidoreductase, transferring electrons received from ETF to ubiquinone rather than serving as the terminal electron acceptor. It accepts electrons from the electron-transferring flavoprotein (ETF), a heterodimeric enzyme located in the mitochondrial matrix that receives reducing equivalents from at least nine mitochondrial flavin-containing dehydrogenases involved in fatty acid β-oxidation and amino acid metabolism. ETFDH then transfers these electrons to ubiquinone (coenzyme Q) in the inner mitochondrial membrane, thereby feeding electrons into the respiratory chain. This electron transfer step is essential for maintaining mitochondrial redox homeostasis and for coupling fatty acid oxidation to oxidative phosphorylation. ETFDH activity is dynamically regulated in response to metabolic conditions, with expression increasing in response to fatty acid treatment and under high-fat diet conditions. Biallelic mutations in ETFDH cause multiple acyl-CoA dehydrogenase deficiency (MADD), also known as glutaric acidemia type II, an autosomal recessive disorder of fatty acid and amino acid oxidation. MADD presents with a spectrum of phenotypes ranging from severe neonatal-onset forms to mild late-onset forms, with ETFDH mutations being the most common cause of the riboflavin-responsive late-onset form. Emerging evidence indicates that reduced ETFDH expression is common in human cancers, where ETF insufficiency driven by ETFDH loss selectively optimizes cancer bioenergetics and promotes tumor growth.

Fig. 1 Conserved Q-binding domain residues Y271 and G273 in ETFDH. (OA Literature)Fig. 1 ETFDH structure highlighting two highly conserved amino acids in the Q-binding domain: Y271 and G273.1

ETFDH Protein Function: Roles in Electron Transfer, Fatty Acid Oxidation, and Mitochondrial Bioenergetics

ETFDH, encoded by the ETFDH gene, functions as a mitochondrial inner membrane flavoprotein that mediates electron transfer from fatty acid β-oxidation to the respiratory chain:

  • Electron Transfer from ETF to Ubiquinone: ETFDH accepts electrons from the electron-transferring flavoprotein (ETF) in the mitochondrial matrix and reduces ubiquinone (coenzyme Q) in the inner mitochondrial membrane, a downstream electron-transfer step connecting fatty acid and amino acid catabolism to the respiratory chain.
  • FAD and 4Fe-4S Cluster Cofactors: ETFDH contains one molecule of FAD and a 4Fe-4S cluster; the FAD is buried deeply within its functional domain in an extended conformation, enabling efficient electron transfer through the enzyme.
  • Three-Domain Architecture and UQ Binding: The monomeric protein comprises three functional domains—an FAD-binding domain, a 4Fe-4S cluster domain, and a UQ-binding domain; two highly conserved amino acids within the UQ-binding domain are required for the interaction between ETFDH and coenzyme Q.
  • Mitochondrial Redox Homeostasis: ETFDH-mediated electron flux into the respiratory chain is required for maintaining mitochondrial redox homeostasis and coupling fatty acid oxidation to oxidative phosphorylation.
  • MADD and Cancer-Associated Dysfunction: Biallelic mutations in ETFDH cause multiple acyl-CoA dehydrogenase deficiency (MADD), and reduced ETFDH expression and metabolic alterations have been reported in selected tumor types and experimental models.

ETFDH Membrane Protein Product

Creative Biolabs provides ETFDH membrane protein products produced using optimized expression systems. These include full-length ETFDH protein that retains the native FAD-binding domain, 4Fe-4S cluster domain, and UQ-binding domain, as well as isolated domain variants. The FAD-binding domain and 4Fe-4S cluster mediate electron transfer, while the UQ-binding domain mediates coenzyme Q interaction and inner membrane association, supporting structural and interaction research; functional electron-transfer studies additionally require validated cofactor loading and an appropriate ETF–ETFDH–ubiquinone assay system. All ETFDH proteins undergo strict quality control to support consistent performance across applicable research platforms.

Custom ETFDH Protein Product

Not finding the protein product you need? Contact us to start your one-stop custom service!

ETFDH Stable Cell Line Product

Creative Biolabs provides custom-engineered ETFDH stable cell lines, including overexpression and knockout models. These cell lines are optimized for studies of mitochondrial electron transfer, fatty acid β-oxidation, mitochondrial redox homeostasis, and ETFDH-associated MADD mechanisms. Each cell line undergoes stringent validation to ensure stable expression profiles and consistent functional performance in diverse experimental contexts.

ETFDH Stable Cell Line Product

Not finding the stable cell line product you need? Contact us to start your one-stop custom service!

ETFDH Recombinant Antibody Product

High-specificity recombinant antibodies targeting ETFDH are developed using antibody engineering techniques for research applications involving ETFDH expression and localization. These antibodies can be used in studies of ETFDH distribution in mitochondrial inner membrane fractions and may also support characterization of ETFDH-containing electron transfer complexes in combination with appropriate detection reagents.

ETFDH Recombinant Antibody Product

Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!

Product Features

  • Electron Transfer Activity: Preserves the FAD-binding domain and 4Fe-4S cluster required for electron transfer from ETF to ubiquinone, supporting studies of mitochondrial electron transfer and flavoprotein dehydrogenase kinetics.
  • UQ Binding and Inner Membrane Association: Retains the UQ-binding domain and conserved residues necessary for coenzyme Q interaction and inner mitochondrial membrane localization.
  • MADD and Mitochondrial Disease Research Compatibility: Optimized reagent series for studies of ETFDH mutations, fatty acid oxidation defects, and mitochondrial redox homeostasis.
  • Comprehensive Customization Support: Facilitates end-to-end development of customized proteins, antibodies and stable cell lines to address mitochondrial electron transfer and fatty acid oxidation research demands.

Custom ETFDH Research Services

Beyond catalog products, Creative Biolabs offers specialized custom services for ETFDH research:

  • Custom ETFDH Protein Production: Tailored expression of mutant and tagged ETFDH constructs for electron transfer and coenzyme Q binding studies.
  • Custom Antibody Development: Generation of ETFDH-specific antibodies for immunostaining, flow cytometry, and protein detection applications.
  • Stable Cell Line Engineering: Construction of ETFDH-modified cell models for mitochondrial electron transfer, fatty acid oxidation, and MADD research.
  • Functional Assay Development: Custom design of electron transfer activity, ubiquinone reduction, and mitochondrial respiration detection workflows.

Frequently Asked Questions (FAQs)

  1. What is the primary function of ETFDH?

    ETFDH is a mitochondrial inner membrane flavoprotein that accepts electrons from the electron-transferring flavoprotein and reduces ubiquinone, the terminal step of electron transfer from fatty acid β-oxidation to the respiratory chain.

  2. Why is ETFDH a significant research target?

    ETFDH is essential for mitochondrial electron transfer and fatty acid oxidation, and its mutations cause multiple acyl-CoA dehydrogenase deficiency (MADD), the most common cause of riboflavin-responsive late-onset MADD. It is also downregulated in multiple cancers, making it important for studies of mitochondrial metabolism and metabolic disease mechanisms.

  3. Are Creative Biolabs' ETFDH products suitable for clinical use?

    No, all ETFDH products and services are strictly for research use only, not intended for clinical diagnosis or treatment.

  4. What types of ETFDH products does Creative Biolabs offer?

    Offerings include full-length ETFDH membrane proteins, domain variants, specific detection antibodies, and custom stable cell lines for mitochondrial electron transfer and fatty acid oxidation research.

  5. What research applications can ETFDH proteins support?

    ETFDH proteins may support research on electron transfer activity and ubiquinone reduction, depending on protein format and experimental context.

Reference
  1. Herrero Martín, J.C., et al. "An ETFDH-driven metabolon supports OXPHOS efficiency in skeletal muscle by regulating coenzyme Q homeostasis." Nature Metabolism 6 (2024): 209–225. Under Open Access license CC BY 4.0, without modification. https://doi.org/10.1038/s42255-023-00956-y
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2026 Creative Biolabs. | Contact Us
Thanksgiving Sale - up to 20% off membrane proteins and stable cell lines
Membrane Proteins Stable Cell Lines
;